Archives of Dermatological Research

, Volume 300, Issue 3, pp 125–131

A study of the pathogenesis of Rosacea: how angiogenesis and mast cells may participate in a complex multifactorial process

  • Kyriaki Aroni
  • Eugenia Tsagroni
  • Nikolaos Kavantzas
  • Efstratios Patsouris
  • Eleftherios Ioannidis
Original Paper


In the present study we evaluated, in involved and clinically uninvolved skin of Rosacea, microvessels density (MVD) and total vascular area (TVA) in addition to multiple morphologic characteristics of microvessels and also mast cells (MCs) number. We examined also the relationship between angiogenesis, MCs number and disease clinicopathological data. The study included 69 patients with Rosacea. A skin biopsy with a 4-mm punch was performed from clinically involved skin in each case. In nine randomly selected patients, facial biopsy specimens were obtained from both involved and clinically uninvolved skin. Histological sections, immunostained for factor VIII, were evaluated by image analysis for the quantification of MVD, TVA and several morphometric parameters related to the vessel size or shape. MCs detection in the dermis was carried out using the chloracetate esterase method (Fast Blue RR) in parafin sections. Serum antibodies against H.pylori were detected. Statistically important differences concerning the factors of angiogenesis between lesional and clinically non-lesional skin were demonstrated. A statistical important correlation was found also between high vascular density, PPR clinical type and the presence of ocular manifestations. MVD or TVA showed no correlation with the degree of solar elastosis or inflammation and with the Demodex density as well. However, high MVD values were found to correlate with granuloma formation in the dermis. MCs number were significantly greater in lesional compared to clinically non-lesional skin. Statistical significance was shown between MCs density and disease duration. However, no correlation between MCs number and blood vessel density was found. Angiogenesis seems to play an important role in the pathogenesis especially of the more severe clinical form of Rosacea. MCs seem to participate in evolution to disease chronicity by contributing to inflammation, angiogenesis and tissue fibrosis.


Rosacea Angiogenesis Mast cells 


  1. 1.
    Aloi F, Tomasini C (2000) The clinicopathologic spectrum of rhinophyma. J Am Acad Dermatol 42:468–472PubMedCrossRefGoogle Scholar
  2. 2.
    Aroni K, Tsagroni E, Lazaris A, Patsuris E, Agapitos E (2004) Rosacea: a clinicopathological approach. Dermatology 209:177–182PubMedCrossRefGoogle Scholar
  3. 3.
    Artuc M, Hermes B, Steckelings UM (1999) Mast cells and their mediators in cutaneous wound healing-active participants or innocent bystanders? Exp Dermatol 8:1–16PubMedCrossRefGoogle Scholar
  4. 4.
    Ballaun C, Weninger W (1995) Human Keratinocytes express the three major splice forms of VEGF. J Invest Dermatol 104:7–10PubMedCrossRefGoogle Scholar
  5. 5.
    Bamford J (2001) Rosacea: current thoughts on origin. Sem Cut Med Surg 20(3):199–206CrossRefGoogle Scholar
  6. 6.
    Bancroft JD, Stevens A (1982) Theory and practice of histological techniques, 2nd edn. Churchill Livingstone, Edinburgh, p 402Google Scholar
  7. 7.
    Barton SP, Abdullah MS, Marks R (1992) Quantification of microvascular changes in the skin in patients with psoriasis. Br J Dermatol 126:569–574PubMedCrossRefGoogle Scholar
  8. 8.
    Bielauberg DR, Sanchez R (1998) Molecular regulation of UVB-induced cutaneous angiogenesis. J Invest Dermatol 111:864–872CrossRefGoogle Scholar
  9. 9.
    Bonnar A, Eustace P (1993) The Demodex mite population in Rosacea. JAAD 28:443–448Google Scholar
  10. 10.
    Brown LF, Harrist TJ, Yeo KT, Stable-Backdahl M, Jackman RW, Berse B, Tognazzi K, Dvorak HF, Detmar M (1995) Increased expression of VPF in bullous pemphigoid, dermatitis herpetiformis and erythema multiform. J Invest Dermatol 104:744–749PubMedCrossRefGoogle Scholar
  11. 11.
    Clauss M, Gerlach M, et al (1990) VPF: a tumor derived polypeptide that induces endothelial cell and monocyte procoagulant activity and promotes monocyte migration. J Exp Med 172:1535–1545PubMedCrossRefGoogle Scholar
  12. 12.
    Crawford GH, Pelle MT (2004) Rosacea I. Etiology, pathogenesis and subtype classification. JAAD 51:327–341Google Scholar
  13. 13.
    Detmar M (1996) Molecular regulation of angiogenesis in the skin. J Invest Dermatol 106:207–208PubMedCrossRefGoogle Scholar
  14. 14.
    Erbagci Z, Ozgoztasi O (1998) The significance of Demodex folliculorum density in rosacea. Int J Dermatol 37:421–425PubMedCrossRefGoogle Scholar
  15. 15.
    Folkman J (1995) Clinical applications of research on angiogenesis. N Engl J Med 333:1757–1763PubMedCrossRefGoogle Scholar
  16. 16.
    Forton F, Seys B (1993) Density of Demodex folliculorum in Rosacea:a case-control study using standardized skin-surface biopsy. Br J Dermatol 128:650–659PubMedCrossRefGoogle Scholar
  17. 17.
    Georgala S, Katoulis AC (2001) Increased density of Demodex folliculorum and evidence of delayed hypersensitivity reaction in subjects with papulopustular rosacea. JEADV 15:441–444PubMedGoogle Scholar
  18. 18.
    Gruber LB, Marchese JM, Kew R (1995) Angiogenic factors stimulate Mast-cell migration. Blood 86(7):2488–2493PubMedGoogle Scholar
  19. 19.
    Hagiwara K, Khaskhely MN, Vezato H, Nonaka S (199) Mast cell “Densities” in vascular proliferations: a preliminary study of pyogenic granuloma, Portwine stain, Cavernous Hemangioma, Cherry Angioma, Kaposi’s Sarcoma and Malignant Hemangioendothelioma. J Dermatol 26:577–586Google Scholar
  20. 20.
    Jiang YW, Chattedee DA, Raychaudhuri PS (2001) Mast cell density and IL-8 expression in nonlesional and lesional psoriatic skin. Int J Dermatol 40:699–703PubMedCrossRefGoogle Scholar
  21. 21.
    Katz AM (1998) Rosacea: epidemiology and pathogenesis. J Cut Med Surg 2(Suppl4):S4–S10Google Scholar
  22. 22.
    Kessler AD, Lauger SR, Pless AN, Folkman S (1976) Mast cell and tumor angiogenesis. Int J Cancer 18:703–709PubMedCrossRefGoogle Scholar
  23. 23.
    Kosmadaki MG (2003) UV induces VEGF through a TNF-a independent pathway. FASEB J 17:446–448PubMedGoogle Scholar
  24. 24.
    Leek RD, Hunt NC, et al (2000) Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J Pathol 190(4):430–436PubMedCrossRefGoogle Scholar
  25. 25.
    Meininger CJ, Zetter BR, et al (1992) Mast cells and angiogenesis. Semin Cancer Biol 3:73–77PubMedGoogle Scholar
  26. 26.
    Motley RJ, Banton S, Marks R (1989) The significance of telangiectasia in rosacea. In: Marks R, Plewig G (eds) Acne and related disorders. Martin Dunitz, London, pp 339–344Google Scholar
  27. 27.
    Neumman E, Frithz A (1998) Capillaropathy and Capillaroneogenesis in the pathogenesis of Rosacea. Int J Dermatol 37:263–266CrossRefGoogle Scholar
  28. 28.
    Ono M, Torisu H (1999) Biological impliations of macrophage infiltration in human tumor angiogenesis. Cancer Chemother Pharmacol 43:S69–S71PubMedCrossRefGoogle Scholar
  29. 29.
    Rothe JM, Nowak M, Kerdel AF (1990) The mast cell in health and disease. JAAD 23(4):615–624Google Scholar
  30. 30.
    Shea RC, Prieto GV (1994) Mast cells in angiolipomas and hemangiomas of human skin: are they important for angiogenesis? J Cut Pathol 21:247–251CrossRefGoogle Scholar
  31. 31.
    Smith JR, Lanier VB (2007) Expression of VEGF and its receptors in rosacea. Br J Ophthalmol 91:226–229PubMedCrossRefGoogle Scholar
  32. 32.
    Tope WD, Sangueza OP (1994) Rhinophyma’s fibrous variant histopathology and immunohistochemistry. Am J Dermatopathol 16(3):307–310PubMedCrossRefGoogle Scholar
  33. 33.
    Walton S, DeSouza JE (1983) Variation in mast cell numbers in psoriasis and lichen planus: comparisons with normal skin. Dermatologica 166:236–239PubMedCrossRefGoogle Scholar
  34. 34.
    Weber S, Kruger-Krasagakes S, Grabbe J (1995) Mast cells. Int J Dermatol 34(1):1–10PubMedCrossRefGoogle Scholar
  35. 35.
    Wilkin J, Dahl M (2002) Standard classification of rosacea: report of the national Rosacea society expert committee on the classification and staging of Rosacea. JAAD 46:584–587Google Scholar
  36. 36.
    Wilkin J (1994) Rosacea. Pathophysiology and treatment. Arch Dermatol 130:359–362PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Kyriaki Aroni
    • 1
  • Eugenia Tsagroni
    • 1
  • Nikolaos Kavantzas
    • 1
  • Efstratios Patsouris
    • 1
  • Eleftherios Ioannidis
    • 1
  1. 1.Department of Dermatopathology, Medical SchoolUniversity of AthensAthensGreece

Personalised recommendations